BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hasanzadeh A, Noori H, Jahandideh A, Haeri Moghaddam N, Kamrani Mousavi SM, Nourizadeh H, Saeedi S, Karimi M, Hamblin MR. Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing. ACS Appl Bio Mater 2022. [PMID: 35040621 DOI: 10.1021/acsabm.1c01112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Madhi ZS, Shallan MA, Almaamuri AM, Alhussainy AA, Al- Salih SSS, Raheem AK, Alwan HJ, Jalil AT. Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103948] [Reference Citation Analysis]
2 Rani V, Prabhu A. CRISPR-Cas9 based non-viral approaches in nanoparticle elicited therapeutic delivery. Journal of Drug Delivery Science and Technology 2022;76:103737. [DOI: 10.1016/j.jddst.2022.103737] [Reference Citation Analysis]
3 Caprifico AE, Foot PJS, Polycarpou E, Calabrese G. Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems. Pharmaceutics 2022;14:1840. [DOI: 10.3390/pharmaceutics14091840] [Reference Citation Analysis]
4 Hejabi F, Abbaszadeh MS, Taji S, O’neill A, Farjadian F, Doroudian M. Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems. Front Chem 2022;10:957572. [DOI: 10.3389/fchem.2022.957572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]